{"component": "contracts", "props": {"contracts": [{"intro": "Venaxis, Inc., a Colorado corporation (the \u201cCompany\u201d), proposes to sell to Piper Jaffray & Co. (the \u201cUnderwriter\u201d) an aggregate of [ \u0178 ] shares (the \u201cFirm Shares\u201d) of Common Stock, no par value per share (the \u201cCommon Stock\u201d), of the Company. The Firm Shares consist of [ \u0178 ] authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company has also granted to the Underwriter an option to purchase up to [ \u0178 ] additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the \u201cOption Shares\u201d). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the \u201cSecurities.\u201d", "id": "emWsMFARjoW", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000114420413030288/v345626_ex1-1.htm", "category_name": "Purchase Agreement", "company_name": "Venaxis, Inc.", "created": "May 20th, 2013", "published": true, "pretty": null, "uri": "/contracts/emWsMFARjoW", "title": "\u0178 ] Shares1 Venaxis, Inc. Common Stock PURCHASE AGREEMENT", "group_id": "aSBmOs8h2OQ", "group_samples": [{"label": "Purchase Agreement (S1 Biopharma, Inc.)", "uri": "/contracts/aSBmOs8h2OQ", "published": true}, {"label": "Purchase Agreement (Idera Pharmaceuticals, Inc.)", "uri": "/contracts/dgMnQeMbljf", "published": true}, {"label": "Purchase Agreement (Nanosphere Inc)", "uri": "/contracts/aMbjm8NeREC", "published": true}], "group_size": 15, "tags": [{"name": "Purchase Agreement", "type": "category", "uri": "/contracts/tagged/purchase-agreement"}, {"name": "Venaxis, Inc.", "type": "company", "uri": "/company/1167419/venaxis-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This non-fixed price sales and purchase agreement (this \u201cAgreement\u201d) is made, effective as of December 24, 2021, by and between Bitmain Technologies Limited (\u201cBitmain\u201d) (Company number: [****]), with its registered office at Unit A1 of Unit A, 11th Floor, Success Commercial Building, 245-251 Hennessy Road, Hong Kong, PRC, and Riot Blockchain, Inc., a Nevada corporation (the \u201cPurchaser\u201d), with its principal place of business at 3855 Ambrosia Street, Suite 301, Castle Rock, CO 80109, USA.", "id": "cWlWwVyvOxz", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997322000003/ex10x1.htm", "category_name": "Sales and Purchase Agreement", "company_name": "Riot Blockchain, Inc.", "created": "January 3rd, 2022", "published": true, "pretty": null, "uri": "/contracts/cWlWwVyvOxz", "title": "NON-FIXED PRICE SALES AND PURCHASE AGREEMENT BETWEEN Bitmain Technologies Limited (\u201cBitmain\u201d) AND Riot Blockchain, Inc (\u201cPurchaser\u201d)", "group_id": "bjR7NlOKxK", "group_samples": [{"label": "Sales and Purchase Agreement (Akerna Corp.)", "uri": "/contracts/laFwppf47u", "published": true}, {"label": "Sales and Purchase Agreement (Iris Energy LTD)", "uri": "/contracts/haX0yLab4B4", "published": true}, {"label": "Sales and Purchase Agreement (Terawulf Inc.)", "uri": "/contracts/8GJDFCU2qVD", "published": true}], "group_size": 13, "tags": [{"name": "Sales and Purchase Agreement", "type": "category", "uri": "/contracts/tagged/sales-and-purchase-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "Services-computer processing & data preparation", "type": "industry", "uri": "/contracts/tagged/services-computer-processing-data-preparation"}]}, {"intro": "THIS REGISTRATION RIGHTS AGREEMENT (this \u201cAgreement\u201d), dated as of January 28, 2019 (the \u201cExecution Date\u201d), is entered into by and between RIOT BLOCKCHAIN, INC., a Nevada corporation (the \u201cCompany\u201d), and [___________] (together with its permitted assigns, the \u201cBuyer\u201d). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Securities Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the \u201cPurchase Agreement\u201d).", "id": "2OLbq6mEIoe", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997319000057/ex10x3.htm", "category_name": "Registration Rights Agreement", "company_name": "Riot Blockchain, Inc.", "created": "February 1st, 2019", "published": true, "pretty": null, "uri": "/contracts/2OLbq6mEIoe", "title": "REGISTRATION RIGHTS AGREEMENT", "group_id": "co1CXlrxnYq", "group_samples": [{"label": "Registration Rights Agreement (Cycurion, Inc.)", "uri": "/contracts/kvXlsWzeef", "published": true}, {"label": "Registration Rights Agreement (HCW Biologics Inc.)", "uri": "/contracts/galbN6f6137", "published": true}, {"label": "Registration Rights Agreement (OS Therapies Inc)", "uri": "/contracts/cIi6D6ofsW", "published": true}], "group_size": 13, "tags": [{"name": "Registration Rights Agreement", "type": "category", "uri": "/contracts/tagged/registration-rights-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Kansas", "type": "jurisdiction", "uri": "/contracts/tagged/kansas-us"}]}, {"intro": "THIS COMMON STOCK PURCHASE WARRANT (the \u201cWarrant\u201d) certifies that, for value received (in connection with the funding of that certain senior secured convertible promissory note dated January 28, 2019, in the original principal amount of up to [$________] by the Company (as defined below) to the Lender (as defined below)) (the \u201cNote\u201d), [___________] (the \u201cLender\u201d and including any permitted and registered assigns, the \u201cHolder\u201d), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Riot Blockchain, Inc., a Nevada corporation (the \u201cCompany\u201d), up to [_________] shares of Common Stock (as defined below) (the \u201cWarrant Shares\u201d) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by the Company as of the date hereof pursuant to the", "id": "5MktJssZ7sW", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997319000057/ex4x2.htm", "category_name": "Security Agreement", "company_name": "Riot Blockchain, Inc.", "created": "February 1st, 2019", "published": true, "pretty": null, "uri": "/contracts/5MktJssZ7sW", "title": "COMMON STOCK PURCHASE WARRANT RIOT BLOCKCHAIN, INC.", "group_id": "iOeRM9HC91", "group_samples": [{"label": "Security Agreement (U.S. Lighting Group, Inc.)", "uri": "/contracts/lD17HRX3qcL", "published": true}, {"label": "Security Agreement (Major League Football Inc)", "uri": "/contracts/j5KDxA9Squ0", "published": true}, {"label": "Security Agreement (4Less Group, Inc.)", "uri": "/contracts/1o9sJVYTzmg", "published": true}], "group_size": 12, "tags": [{"name": "Security Agreement", "type": "category", "uri": "/contracts/tagged/security-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Kansas", "type": "jurisdiction", "uri": "/contracts/tagged/kansas-us"}]}, {"intro": "", "id": "fIoB6WeTMjg", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000095013402006833/d95933a1exv10w16xay.txt", "category_name": "Contract to Buy and Sell Real Estate", "company_name": "Aspenbio Inc", "created": "June 6th, 2002", "published": true, "pretty": null, "uri": "/contracts/fIoB6WeTMjg", "title": "EXHIBIT 10.16(a) THIS FORM HAS IMPORTANT LEGAL CONSEQUENCES AND THE PARTIES SHOULD CONSULT LEGAL AND TAX OR OTHER COUNSEL BEFORE SIGNING. CONTRACT TO BUY AND SELL REAL ESTATE (VACANT LAND - FARM - RANCH)", "group_id": "2sLEAwH1NIa", "group_samples": [{"label": "Contract to Buy and Sell Real Estate (Eldorado Artesian Springs Inc)", "uri": "/contracts/burust7EkV9", "published": true}, {"label": "Contract to Buy and Sell Real Estate (Eldorado Artesian Springs Inc)", "uri": "/contracts/iZt6Tl8WFqG", "published": true}, {"label": "Contract to Buy and Sell Real Estate (Eldorado Artesian Springs Inc)", "uri": "/contracts/baswgEI3PaP", "published": true}], "group_size": 10, "tags": [{"name": "Contract to Buy and Sell Real Estate", "type": "category", "uri": "/contracts/tagged/contract-to-buy-and-sell-real-estate"}, {"name": "Aspenbio Inc", "type": "company", "uri": "/company/1167419/aspenbio-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "This agreement (this \u201cAgreement\u201d) is made effective as of 11th Mar, 2021 by and between Bitmain Technologies Limited (\u201cBitmain\u201d) (Company number: [****]), with its registered office at Unit A1 of Unit A, 11th Floor, Success Commercial Building, 245-251 Hennessy Road, Hong Kong, and Riot Blockchain, Inc. (the \u201cPurchaser\u201d), with its principal place of business at 202 6th Street, Suite 401, Castle Rock, CO 80104, USA. Bitmain and the Purchaser shall hereinafter collectively be referred to as the \u201cParties\u201d, and individually as a \u201cParty\u201d.", "id": "ioHRfMWq5z1", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997321000184/ex10x1.htm", "category_name": "Sales and Purchase Agreement", "company_name": "Riot Blockchain, Inc.", "created": "March 17th, 2021", "published": true, "pretty": null, "uri": "/contracts/ioHRfMWq5z1", "title": "SALES AND PURCHASE AGREEMENT BETWEEN Bitmain Technologies Limited (\u201cBitmain\u201d)", "group_id": "6XPJq6Uxn8l", "group_samples": [{"label": "Sales and Purchase Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/ioHRfMWq5z1", "published": true}, {"label": "Sales and Purchase Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/cu9NfvfzxlU", "published": true}, {"label": "Sales and Purchase Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/6xLGPET86Yf", "published": true}], "group_size": 10, "tags": [{"name": "Sales and Purchase Agreement", "type": "category", "uri": "/contracts/tagged/sales-and-purchase-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "Services-computer processing & data preparation", "type": "industry", "uri": "/contracts/tagged/services-computer-processing-data-preparation"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (this \u201cAgreement\u201d), dated as of January 28, 2019, (the \u201cExecution Date\u201d), is entered into by and between RIOT BLOCKCHAIN, INC., a Nevada corporation (the \u201cCompany\u201d), and [__________] (the \u201cBuyer\u201d).", "id": "fOLwMbVr9a2", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997319000057/ex10x1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Riot Blockchain, Inc.", "created": "February 1st, 2019", "published": true, "pretty": null, "uri": "/contracts/fOLwMbVr9a2", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "2TFAh3SHWvz", "group_samples": [{"label": "Securities Purchase Agreement (Jaguar Health, Inc.)", "uri": "/contracts/7mTxuGHnrRv", "published": true}, {"label": "Securities Purchase Agreement (Astro Aerospace Ltd.)", "uri": "/contracts/cqJiR9UGPAD", "published": true}, {"label": "Securities Purchase Agreement (Predictive Oncology Inc.)", "uri": "/contracts/8bE7XB5ppvD", "published": true}], "group_size": 8, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Kansas", "type": "jurisdiction", "uri": "/contracts/tagged/kansas-us"}]}, {"intro": "This Agreement is made pursuant to a Purchase Agreement, dated as of the date hereof between the Company and the Investor (the \u201cSPA\u201d), relating to shares of the Company\u2019s Common Stock issued to the Investor in connection therewith (this Agreement, together with SPA, the \u201cInvestment Documents\u201d).", "id": "6DJQlYMMH13", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000667/ex10x3.htm", "category_name": "Registration Rights Agreement", "company_name": "Riot Blockchain, Inc.", "created": "November 13th, 2017", "published": true, "pretty": null, "uri": "/contracts/6DJQlYMMH13", "title": "REGISTRATION RIGHTS AGREEMENT", "group_id": "21iN5EMjX13", "group_samples": [{"label": "Registration Rights Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/6DJQlYMMH13", "published": true}, {"label": "Registration Rights Agreement (DDS Technologies Usa Inc)", "uri": "/contracts/3y3KDIafkj8", "published": true}, {"label": "Registration Rights Agreement (American Technology Corp /De/)", "uri": "/contracts/epRMBBZeS4K", "published": true}], "group_size": 7, "tags": [{"name": "Registration Rights Agreement", "type": "category", "uri": "/contracts/tagged/registration-rights-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS COMMON STOCK PURCHASE WARRANT (the \"Warrant\") certifies that, for value received, [______] or its assigns (the \"Holder\") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Issuance Date (the \"Initial Exercise Date\") and on or prior to the close of business on the thirty six (36) month anniversary of the Initial Exercise Date (the \"Termination Date\") but not thereafter, to subscribe for and purchase from BIOPTIX, INC., a Colorado corporation (the \"Company\"), up to [____] shares (as subject to adjustment hereunder, the \"Warrant Shares\") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).", "id": "6Yt211BzWsj", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000167/ex4x2.htm", "category_name": "Security Agreement", "company_name": "Bioptix, Inc.", "created": "March 17th, 2017", "published": true, "pretty": null, "uri": "/contracts/6Yt211BzWsj", "title": "FORM OF COMMON STOCK PURCHASE WARRANT", "group_id": "3XxzK6xBk28", "group_samples": [{"label": "Security Agreement (Summit Wireless Technologies, Inc.)", "uri": "/contracts/4OIfreQtS41", "published": true}, {"label": "Security Agreement (Digital Power Corp)", "uri": "/contracts/kTs98GmKPZt", "published": true}, {"label": "Security Agreement (Iroquois Capital Management, LLC)", "uri": "/contracts/la9mSoc6Qtg", "published": true}], "group_size": 7, "tags": [{"name": "Security Agreement", "type": "category", "uri": "/contracts/tagged/security-agreement"}, {"name": "Bioptix, Inc.", "type": "company", "uri": "/company/1167419/bioptix-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "", "id": "bust5OvT0JT", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000095013402006833/d95933a1exv10w16xby.txt", "category_name": "Agreement to Amend/Extend Contract", "company_name": "Aspenbio Inc", "created": "June 6th, 2002", "published": true, "pretty": null, "uri": "/contracts/bust5OvT0JT", "title": "EXHIBIT 10.16(b) THIS FORM AS IMPORTANT LEGAL CONSEQUENCES AND THE PARTIES SHOULD CONSULT LEGAL AND TAX OR OTHER COUNSEL BEFORE SIGNING. AGREEMENT TO AMEND/EXTEND CONTRACT", "group_id": "4KisxvC2nrD", "group_samples": [{"label": "Agreement to Amend/Extend Contract (Molecular Diagnostics & Therapeutics Inc)", "uri": "/contracts/7p5oOYIfaHh", "published": true}, {"label": "Agreement to Amend/Extend Contract (Aspenbio Inc)", "uri": "/contracts/eituh2oLeTk", "published": true}, {"label": "Agreement to Amend/Extend Contract (Bishop Capital Corp)", "uri": "/contracts/d2BGGSkWGhr", "published": true}], "group_size": 7, "tags": [{"name": "Agreement to Amend/Extend Contract", "type": "category", "uri": "/contracts/tagged/agreement-to-amend-extend-contract"}, {"name": "Aspenbio Inc", "type": "company", "uri": "/company/1167419/aspenbio-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "This Executive Employment Agreement (this \u201cAgreement\u201d) is made and entered into, effective as of January 1, 2026 (the \u201cEffective Date\u201d), by and between Jason Les (\u201cEmployee\u201d), [***], and Riot Platforms, Inc., a Nevada corporation (\u201cRiot\u201d and, together with its consolidated subsidiaries, the \u201cCompany\u201d). Employee and the Company are sometimes referred to herein collectively as the \u201cParties\u201d and each, individually, as a \u201cParty\u201d to this Agreement.", "id": "9yTIdwWwixr", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000110465926053120/riot-20260331xex10d8.htm", "category_name": "Executive Employment Agreement", "company_name": "Riot Platforms, Inc.", "created": "April 30th, 2026", "published": true, "pretty": null, "uri": "/contracts/9yTIdwWwixr", "title": "CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "9yTIdwWwixr", "group_samples": [{"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/dhpEI5dZish", "published": true}, {"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/irFeJpF6yHx", "published": true}, {"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/fh03evKhIee", "published": true}], "group_size": 5, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Riot Platforms, Inc.", "type": "company", "uri": "/company/1167419/riot-platforms-inc"}, {"name": "Finance services", "type": "industry", "uri": "/contracts/tagged/finance-services"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "This Executive Employment Agreement (this \u201cAgreement\u201d) is made and entered into, effective as of January 1, 2026 (the \u201cEffective Date\u201d), by and between Benjamin Yi (\u201cEmployee\u201d), an individual resident of the Cayman Islands, and Riot Cayman, a limited company organized under the laws of the Cayman Islands, for itself and its affiliate, Riot Platforms, Inc., a Nevada corporation, (\u201cRiot\u201d or the \u201cCompany\u201d). Employee and the Company are sometimes referred to herein collectively as the \u201cParties\u201d and each, individually, as a \u201cParty\u201d to this Agreement.", "id": "1YUokUeSOku", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000110465926022322/riot-20251231xex10d20.htm", "category_name": "Executive Employment Agreement", "company_name": "Riot Platforms, Inc.", "created": "March 2nd, 2026", "published": true, "pretty": null, "uri": "/contracts/1YUokUeSOku", "title": "AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "1YUokUeSOku", "group_samples": [{"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/1YUokUeSOku", "published": true}, {"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/4eIoQoU6pBp", "published": true}, {"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/2bEPHDOuAdY", "published": true}], "group_size": 4, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Riot Platforms, Inc.", "type": "company", "uri": "/company/1167419/riot-platforms-inc"}, {"name": "Finance services", "type": "industry", "uri": "/contracts/tagged/finance-services"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "", "id": "i2EvlblY2W4", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000095013402003703/d95933ex10-2a.txt", "category_name": "Securities Purchase Agreement", "company_name": "Aspenbio Inc", "created": "April 12th, 2002", "published": true, "pretty": null, "uri": "/contracts/i2EvlblY2W4", "title": "EXHIBIT 10.2(a) ASPENBIO, INC. SECURITIES PURCHASE AGREEMENT DECEMBER 28, 2001 TABLE OF CONTENTS", "group_id": "6jKfHrhcod7", "group_samples": [{"label": "Securities Purchase Agreement (Broadcast International Inc)", "uri": "/contracts/4ISstkO29nS", "published": true}, {"label": "Securities Purchase Agreement (Axess Corp)", "uri": "/contracts/6jKfHrhcod7", "published": true}, {"label": "Securities Purchase Agreement (Pacific Aerospace & Electronics Inc)", "uri": "/contracts/7PirecjnF8E", "published": true}], "group_size": 4, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Aspenbio Inc", "type": "company", "uri": "/company/1167419/aspenbio-inc"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "", "id": "2vv8Sn3W5xA", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000114420413031197/v346041_ex1-1.htm", "category_name": "Purchase Agreement", "company_name": "Venaxis, Inc.", "created": "May 23rd, 2013", "published": true, "pretty": null, "uri": "/contracts/2vv8Sn3W5xA", "title": "\u0178 ] Shares of Common Stock1 and Warrants to Purchase [ \u0178 ] Shares of Common Stock Venaxis, Inc. PURCHASE AGREEMENT", "group_id": "hqQFNLMqAFg", "group_samples": [{"label": "Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/i5EEcrmps09", "published": true}, {"label": "Purchase Agreement (Sophiris Bio Inc.)", "uri": "/contracts/hqQFNLMqAFg", "published": true}, {"label": "Purchase Agreement (Magnegas Corp)", "uri": "/contracts/8h015RMwk9S", "published": true}], "group_size": 4, "tags": [{"name": "Purchase Agreement", "type": "category", "uri": "/contracts/tagged/purchase-agreement"}, {"name": "Venaxis, Inc.", "type": "company", "uri": "/company/1167419/venaxis-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "Introductory. AspenBio Pharma, Inc., a Colorado corporation (the \u201cCompany\u201d), proposes to issue and sell (the \u201cOffering\u201d) to ThinkEquity LLC (the \u201cUnderwriter\u201d) an aggregate of 4,482,609 shares (the \u201cUnderwritten Securities\u201d) of the Company\u2019s common stock, no par value per share (the \u201cCommon Stock\u201d). The Company also proposes to issue and sell at the Underwriter\u2019s option, solely to cover over-allotments, an aggregate of up to 672,391 additional shares of Common Stock (the \u201cOption Securities\u201d, and together with the Underwritten Securities, the \u201cSecurities\u201d) as set forth below.", "id": "jVtj4JgCB5E", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997309000942/appy_8k-ex1x1.htm", "category_name": "Underwriting Agreement", "company_name": "AspenBio Pharma, Inc.", "created": "October 7th, 2009", "published": true, "pretty": null, "uri": "/contracts/jVtj4JgCB5E", "title": "Common Stock (no par value) Underwriting Agreement", "group_id": "jVtj4JgCB5E", "group_samples": [{"label": "Underwriting Agreement (CVD Equipment Corp)", "uri": "/contracts/l6X0QnwOpdW", "published": true}, {"label": "Underwriting Agreement (LGL Group Inc)", "uri": "/contracts/5fRuuRcQMrh", "published": true}, {"label": "Underwriting Agreement (Oragenics Inc)", "uri": "/contracts/kQQk2AhYOhR", "published": true}], "group_size": 4, "tags": [{"name": "Underwriting Agreement", "type": "category", "uri": "/contracts/tagged/underwriting-agreement"}, {"name": "AspenBio Pharma, Inc.", "type": "company", "uri": "/company/1167419/aspenbio-pharma-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \"Agreement\") is dated as of December__, 2017, between Riot Blockchain, Inc., a Nevada corporation (the \"Company\"), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a \"Purchaser\" and collectively, the \"Purchasers\").", "id": "2gPV8cEp0rE", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000747/ex10x1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Riot Blockchain, Inc.", "created": "December 19th, 2017", "published": true, "pretty": null, "uri": "/contracts/2gPV8cEp0rE", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "2gPV8cEp0rE", "group_samples": [{"label": "Securities Purchase Agreement (Mabvax Therapeutics Holdings, Inc.)", "uri": "/contracts/7jUyFVWJT8C", "published": true}, {"label": "Securities Purchase Agreement (Mabvax Therapeutics Holdings, Inc.)", "uri": "/contracts/fCKCzlpiT8", "published": true}, {"label": "Securities Purchase Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/2gPV8cEp0rE", "published": true}], "group_size": 3, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Executive Employment Agreement (this \u201cAgreement\u201d) is made and entered into, effective as of [\u2022], 20[\u2022] (the \u201cEffective Date\u201d), by and between [\u2022] (\u201cEmployee\u201d), an individual resident of [\u2022], and Riot Platforms, Inc., a Nevada corporation (\u201cRiot\u201d and, together with its consolidated subsidiaries, the \u201cCompany\u201d). Employee and the Company are sometimes referred to herein collectively as the \u201cParties\u201d and each, individually, as a \u201cParty\u201d to this Agreement.", "id": "3jGKz3PToC2", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000155837024015936/riot-20241120xex10d1.htm", "category_name": "Executive Employment Agreement", "company_name": "Riot Platforms, Inc.", "created": "November 26th, 2024", "published": true, "pretty": null, "uri": "/contracts/3jGKz3PToC2", "title": "AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "3jGKz3PToC2", "group_samples": [{"label": "Executive Employment Agreement (Riot Platforms, Inc.)", "uri": "/contracts/3jGKz3PToC2", "published": true}, {"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/jgD5gvgxx6Z", "published": true}, {"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/8vljtjA2Fhq", "published": true}], "group_size": 3, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Riot Platforms, Inc.", "type": "company", "uri": "/company/1167419/riot-platforms-inc"}, {"name": "Finance services", "type": "industry", "uri": "/contracts/tagged/finance-services"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "This EXECUTIVE EMPLOYMENT AGREEMENT (\"Agreement\") is made and entered into as of the 27th day of February 2018 (the \"Effective Date\", by and between Riot Blockchain Canada Inc., a company incorporated in British Columbia with a registered and records office at Suite 2300 \u2013 550 Burrard Street, Vancouver, British Columbia (\"Company\") and wholly-owned subsidiary of Riot Blockchain, Inc. (\"Parent\") and Robby Chang, an individual (\"Executive\").", "id": "8EMQJfaAQke", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997318000127/ex10x2.htm", "category_name": "Executive Employment Agreement", "company_name": "Riot Blockchain, Inc.", "created": "February 28th, 2018", "published": true, "pretty": null, "uri": "/contracts/8EMQJfaAQke", "title": "EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "8RKdGRHkORX", "group_samples": [{"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/8EMQJfaAQke", "published": true}, {"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/SenfaFDcnD", "published": true}, {"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/8RKdGRHkORX", "published": true}], "group_size": 3, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Ontario", "type": "jurisdiction", "uri": "/contracts/tagged/ontario-ca"}]}, {"intro": "This Executive Employment Agreement (the \u201cAgreement\u201d) is made and entered into by and between Megan Brooks (the \u201cEmployee\u201d) and Riot Blockchain, Inc., a Nevada corporation (the \u201cCompany\u201d). Employee and the Company shall sometimes be referred to herein as the \u201cParties\u201d, with each of Employee and the Company a \u201cParty\u201d to this Agreement.", "id": "1vHoL6KxhEY", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997321000253/ex10x2.htm", "category_name": "Executive Employment Agreement", "company_name": "Riot Blockchain, Inc.", "created": "April 7th, 2021", "published": true, "pretty": null, "uri": "/contracts/1vHoL6KxhEY", "title": "RIOT BLOCKCHAIN, INC. EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "1XPxatH9C8L", "group_samples": [{"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/1vHoL6KxhEY", "published": true}, {"label": "Executive Employment Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/1XPxatH9C8L", "published": true}], "group_size": 2, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "Services-computer processing & data preparation", "type": "industry", "uri": "/contracts/tagged/services-computer-processing-data-preparation"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "THIS RETENTION AGREEMENT (this \u201cAgreement\u201d) is entered into as of the 30th day of June, 2017 (the \u201cEffective Date\u201d) by and between Jeff McGonegal (the \u201cEmployee\u201d) and Bioptix, Inc., a Colorado corporation, and subsidiaries (the \u201cCompany\u201d, and together with the Employee, the \u201cParties\u201d).", "id": "2fw4v5Uur6t", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000374/ex10x1.htm", "category_name": "Retention Agreement", "company_name": "Bioptix, Inc.", "created": "July 3rd, 2017", "published": true, "pretty": null, "uri": "/contracts/2fw4v5Uur6t", "title": "RETENTION AGREEMENT", "group_id": "2fw4v5Uur6t", "group_samples": [{"label": "Retention Agreement", "uri": "/contracts/aIbJuNcZxxj", "published": true}, {"label": "Retention Agreement (Bioptix, Inc.)", "uri": "/contracts/2fw4v5Uur6t", "published": true}], "group_size": 2, "tags": [{"name": "Retention Agreement", "type": "category", "uri": "/contracts/tagged/retention-agreement"}, {"name": "Bioptix, Inc.", "type": "company", "uri": "/company/1167419/bioptix-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "THIS INVESTMENT AGREEMENT (this \"Agreement\") is entered into as of __________, 2016, by and between Venaxis, Inc., a corporation organized under the Laws of the State of Colorado (\"Venaxis\"), [an individual [not] residing in India/a company [not] organized under the Laws of India] (\"Subscriber\"). Venaxis and Subscriber are collectively referred to herein as the \"parties\".", "id": "4QZhpX56Twm", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997316000774/ex10x4.htm", "category_name": "Investment Agreement", "company_name": "Venaxis, Inc.", "created": "January 27th, 2016", "published": true, "pretty": null, "uri": "/contracts/4QZhpX56Twm", "title": "INVESTMENT AGREEMENT by and between VENAXIS, INC. And dated as of", "group_id": "4QZhpX56Twm", "group_samples": [{"label": "Investment Agreement (Venaxis, Inc.)", "uri": "/contracts/4QZhpX56Twm", "published": true}, {"label": "Investment Agreement (Venaxis, Inc.)", "uri": "/contracts/6KGPwYfEGyC", "published": true}], "group_size": 2, "tags": [{"name": "Investment Agreement", "type": "category", "uri": "/contracts/tagged/investment-agreement"}, {"name": "Venaxis, Inc.", "type": "company", "uri": "/company/1167419/venaxis-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "THIS AGREEMENT AND PLAN OF MERGER (this \u201cAgreement\u201d), dated as of December 23, 2022, is by and between Riot Blockchain, Inc., a Nevada corporation (\u201cParent\u201d), and Riot Platforms, Inc., a Nevada corporation and a direct, wholly-owned subsidiary of Parent (\u201cMerger Sub\u201d). Parent and Merger Sub are sometimes collectively referred to as the \u201cConstituent Corporations\u201d in this Agreement.", "id": "5EJmI87bTSp", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997323000004/ex2x1.htm", "category_name": "Merger Agreement", "company_name": "Riot Platforms, Inc.", "created": "January 3rd, 2023", "published": true, "pretty": null, "uri": "/contracts/5EJmI87bTSp", "title": "AGREEMENT AND Plan of Merger", "group_id": "4bc12gZ80nL", "group_samples": [{"label": "Merger Agreement (ESG Inc.)", "uri": "/contracts/4bc12gZ80nL", "published": true}, {"label": "Merger Agreement (Riot Platforms, Inc.)", "uri": "/contracts/5EJmI87bTSp", "published": true}], "group_size": 2, "tags": [{"name": "Merger Agreement", "type": "category", "uri": "/contracts/tagged/merger-agreement"}, {"name": "Riot Platforms, Inc.", "type": "company", "uri": "/company/1167419/riot-platforms-inc"}, {"name": "Services-computer processing & data preparation", "type": "industry", "uri": "/contracts/tagged/services-computer-processing-data-preparation"}, {"name": "Nevada", "type": "jurisdiction", "uri": "/contracts/tagged/nevada-us"}]}, {"intro": "This ASSET PURCHASE AGREEMENT (this \"Agreement\"), is dated as of February 15, 2018, by and among the companies and Prive Technologies LLC, on behalf of the persons and entities which have executed that certain General Assignment, Bill of Sale and Assumption Agreement (the \"Bill of Sale\"), each Bill of Sale which is attached to this Agreement as Exhibit A (collectively, the \"Seller\"), Riot Blockchain Inc., a corporation organized under the laws of the State of Nevada (\"Parent\") and Kairos Global Technology Inc., a Nevada corporation and wholly owned subsidiary of the Parent (\"Acquisition Co.\").", "id": "4vWEfWAzHsi", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997318000112/ex10x1.htm", "category_name": "Asset Purchase Agreement", "company_name": "Riot Blockchain, Inc.", "created": "February 16th, 2018", "published": true, "pretty": null, "uri": "/contracts/4vWEfWAzHsi", "title": "ASSET PURCHASE AGREEMENT", "group_id": "4vWEfWAzHsi", "group_samples": [{"label": "Asset Purchase Agreement", "uri": "/contracts/aqjuJFmvXam", "published": true}, {"label": "Asset Purchase Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/4vWEfWAzHsi", "published": true}], "group_size": 2, "tags": [{"name": "Asset Purchase Agreement", "type": "category", "uri": "/contracts/tagged/asset-purchase-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS EXECUTIVE EMPLOYMENT AGREEMENT (the \u201cAgreement\u201d), dated as of the 23rd day of May, 2012, is by and between AspenBio Pharma, Inc., a Colorado corporation (the \u201cEmployer\u201d or \u201cCompany\u201d) and Don Hurd (the \u201cExecutive\u201d). In consideration of the mutual covenants contained in this Agreement, the Employer agrees to employ the Executive, and the Executive agrees to be employed by the Employer, upon the terms and conditions hereinafter set forth.", "id": "alkIniPHHl5", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997312000413/ex10x1.htm", "category_name": "Executive Employment Agreement", "company_name": "AspenBio Pharma, Inc.", "created": "May 24th, 2012", "published": true, "pretty": null, "uri": "/contracts/alkIniPHHl5", "title": "EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "51juxVQhEFL", "group_samples": [{"label": "Executive Employment Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/alkIniPHHl5", "published": true}, {"label": "Executive Employment Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/51juxVQhEFL", "published": true}], "group_size": 2, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "AspenBio Pharma, Inc.", "type": "company", "uri": "/company/1167419/aspenbio-pharma-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "THIS AGREEMENT dated as of the 19th day of January 2010, to be effective as of the 1st day of January 2010, by and between, AspenBio Pharma, Inc., a Colorado corporation (the \"Employer\" or \"Company\") and Gregory L. Bennett (the \"Executive\"). In consideration of the mutual covenants contained in this Agreement, the Employer agrees to employ the Executive and the Executive agrees to be employed by the Employer upon the terms and conditions hereinafter set forth.", "id": "7CmDJmkz65e", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997310000296/ex10x12.htm", "category_name": "Executive Employment Agreement", "company_name": "AspenBio Pharma, Inc.", "created": "March 9th, 2010", "published": true, "pretty": null, "uri": "/contracts/7CmDJmkz65e", "title": "EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "7CmDJmkz65e", "group_samples": [{"label": "Executive Employment Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/7CmDJmkz65e", "published": true}, {"label": "Executive Employment Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/aPP2vwbVF9X", "published": true}], "group_size": 2, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "AspenBio Pharma, Inc.", "type": "company", "uri": "/company/1167419/aspenbio-pharma-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "This ESCROW DEPOSIT AGREEMENT (this \"Agreement\") dated as of this [__] day of March 2017 by and among BIOPTIX, INC., a Colorado corporation (the \"Company\"), having an address at 1775 38th Street, Boulder, CO 80301, [__] (the \"Lead Investor\") and CORPORATE STOCK TRANSFER, INC. (the \"Escrow Agent\"), a stock transfer agent, having an office at 3200 Cherry Creek South Drive, Suite 430, Denver, CO 80209. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Securities Purchase Agreement, dated [___], 2017 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the \"Purchase Agreement\").", "id": "7P7h1YkSBel", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000167/ex10x4.htm", "category_name": "Escrow Deposit Agreement", "company_name": "Bioptix, Inc.", "created": "March 17th, 2017", "published": true, "pretty": null, "uri": "/contracts/7P7h1YkSBel", "title": "ESCROW DEPOSIT AGREEMENT", "group_id": "7P7h1YkSBel", "group_samples": [{"label": "Escrow Deposit Agreement (Bioptix, Inc.)", "uri": "/contracts/7P7h1YkSBel", "published": true}, {"label": "Escrow Deposit Agreement (Bioptix, Inc.)", "uri": "/contracts/alvE2VVthT8", "published": true}], "group_size": 2, "tags": [{"name": "Escrow Deposit Agreement", "type": "category", "uri": "/contracts/tagged/escrow-deposit-agreement"}, {"name": "Bioptix, Inc.", "type": "company", "uri": "/company/1167419/bioptix-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This ESCROW DEPOSIT AGREEMENT (this \"Agreement\") dated as of this [__] day of March 2017 by and among BIOPTIX, INC., a Colorado corporation (the \"Company\"), having an address at 1775 38th Street, Boulder, CO 80301, [__] (the \"Lead Investor\") and SIGNATURE BANK (the \"Escrow Agent\"), a New York State chartered bank, having an office at 950 Third Avenue, 9th Floor. New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Securities Purchase Agreement, dated March ____, 2017 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the \"Purchase Agreement\").", "id": "gZTgQVahjF4", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000167/ex10x3.htm", "category_name": "Escrow Deposit Agreement", "company_name": "Bioptix, Inc.", "created": "March 17th, 2017", "published": true, "pretty": null, "uri": "/contracts/gZTgQVahjF4", "title": "ESCROW DEPOSIT AGREEMENT", "group_id": "8BIXu4Af3VF", "group_samples": [{"label": "Escrow Deposit Agreement (Bioptix, Inc.)", "uri": "/contracts/gZTgQVahjF4", "published": true}, {"label": "Escrow Deposit Agreement (Bioptix, Inc.)", "uri": "/contracts/8BIXu4Af3VF", "published": true}], "group_size": 2, "tags": [{"name": "Escrow Deposit Agreement", "type": "category", "uri": "/contracts/tagged/escrow-deposit-agreement"}, {"name": "Bioptix, Inc.", "type": "company", "uri": "/company/1167419/bioptix-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This settlement agreement is made as of September 23, 2024 (the \u201cAgreement\u201d) by and between Bitfarms Ltd. (\u201cBitfarms\u201d or the \u201cCompany\u201d) and Riot Platforms, Inc. (\u201cRiot\u201d), who have each agreed to be bound by this Agreement (together, the \u201cParties\u201d and each a \u201cParty\u201d).", "id": "aqiDzxFxOrt", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000110465924101875/tm2424523d1_ex1.htm", "category_name": "Settlement Agreement", "company_name": "Riot Platforms, Inc.", "created": "September 23rd, 2024", "published": true, "pretty": null, "uri": "/contracts/aqiDzxFxOrt", "title": "SETTLEMENT AGREEMENT", "group_id": "aqiDzxFxOrt", "group_samples": [{"label": "Settlement Agreement (Bitfarms LTD)", "uri": "/contracts/gMqv7FQWPw4", "published": true}, {"label": "Settlement Agreement (Riot Platforms, Inc.)", "uri": "/contracts/aqiDzxFxOrt", "published": true}], "group_size": 2, "tags": [{"name": "Settlement Agreement", "type": "category", "uri": "/contracts/tagged/settlement-agreement"}, {"name": "Riot Platforms, Inc.", "type": "company", "uri": "/company/1167419/riot-platforms-inc"}, {"name": "Finance services", "type": "industry", "uri": "/contracts/tagged/finance-services"}]}, {"intro": "THIS AGREEMENT dated as of the 2nd day of February 2009, to be effective as of the 10th day of February 2009, by and between, AspenBio Pharma, Inc., a Colorado corporation (the \u201cEmployer\u201d or \u201cCompany\u201d) and Jeffrey McGonegal (the \u201cExecutive\u201d). In consideration of the mutual covenants contained in this Agreement, the Employer agrees to employ the Executive and the Executive agrees to be employed by the Employer upon the terms and conditions hereinafter set forth.", "id": "hBLYci7M1N", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997309000180/appy_8k-ex10x2.htm", "category_name": "Executive Employment Agreement", "company_name": "AspenBio Pharma, Inc.", "created": "February 17th, 2009", "published": true, "pretty": null, "uri": "/contracts/hBLYci7M1N", "title": "EXECUTIVE EMPLOYMENT AGREEMENT", "group_id": "hBLYci7M1N", "group_samples": [{"label": "Executive Employment Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/hBLYci7M1N", "published": true}, {"label": "Executive Employment Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/lmSw2IYaePi", "published": true}], "group_size": 2, "tags": [{"name": "Executive Employment Agreement", "type": "category", "uri": "/contracts/tagged/executive-employment-agreement"}, {"name": "AspenBio Pharma, Inc.", "type": "company", "uri": "/company/1167419/aspenbio-pharma-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "Colorado", "type": "jurisdiction", "uri": "/contracts/tagged/colorado-us"}]}, {"intro": "The undersigned (the \u201cInvestor\u201d) hereby confirms its agreement with AspenBio Pharma, Inc., a Colorado corporation (the \u201cCompany\u201d), as follows:", "id": "jdxOOpfs17d", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997310000531/ex10x1.htm", "category_name": "Subscription Agreement", "company_name": "AspenBio Pharma, Inc.", "created": "April 30th, 2010", "published": true, "pretty": null, "uri": "/contracts/jdxOOpfs17d", "title": "SUBSCRIPTION AGREEMENT", "group_id": "hLBTs3K8Bfu", "group_samples": [{"label": "Subscription Agreement (AspenBio Pharma, Inc.)", "uri": "/contracts/jdxOOpfs17d", "published": true}, {"label": "Subscription Agreement (Altair Nanotechnologies Inc)", "uri": "/contracts/hLBTs3K8Bfu", "published": true}], "group_size": 2, "tags": [{"name": "Subscription Agreement", "type": "category", "uri": "/contracts/tagged/subscription-agreement"}, {"name": "AspenBio Pharma, Inc.", "type": "company", "uri": "/company/1167419/aspenbio-pharma-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "", "id": "j9Z9OI3V6f1", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000155837025008138/riot-20250519xex10d1.htm", "category_name": "Credit Agreement", "company_name": "Riot Platforms, Inc.", "created": "May 23rd, 2025", "published": true, "pretty": null, "uri": "/contracts/j9Z9OI3V6f1", "title": "AMENDED AND RESTATED CREDIT AGREEMENT Dated as of May 19, 2025 Between RIOT PLATFORMS, INC. as Borrower and COINBASE CREDIT, INC. as Lender, Collateral Agent and Administrative Agent", "group_id": "j9Z9OI3V6f1", "group_samples": [{"label": "Credit Agreement (Riot Platforms, Inc.)", "uri": "/contracts/jEnxvnoJxYP", "published": true}, {"label": "Credit Agreement (Riot Platforms, Inc.)", "uri": "/contracts/j9Z9OI3V6f1", "published": true}], "group_size": 2, "tags": [{"name": "Credit Agreement", "type": "category", "uri": "/contracts/tagged/credit-agreement"}, {"name": "Riot Platforms, Inc.", "type": "company", "uri": "/company/1167419/riot-platforms-inc"}, {"name": "Finance services", "type": "industry", "uri": "/contracts/tagged/finance-services"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "", "id": "jO5pRSVcasr", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997304000694/aspenbio8k_ex1025a.txt", "category_name": "Employment Agreement", "company_name": "Aspenbio Inc", "created": "December 10th, 2004", "published": true, "pretty": null, "uri": "/contracts/jO5pRSVcasr", "title": "Exhibit 10.25 (a) AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment to Employment Agreement is entered into effective December 8, 2004 by and between AspenBio, Inc. (the \"Company\") and Roger Hurst (\"Hurst\"). WHEREAS, the Board of Directors and Hurst...", "group_id": "jO5pRSVcasr", "group_samples": [{"label": "Employment Agreement (Youth Stream Media Networks Inc)", "uri": "/contracts/bGr1TTqa4uQ", "published": true}, {"label": "Employment Agreement (Aspenbio Inc)", "uri": "/contracts/jO5pRSVcasr", "published": true}], "group_size": 2, "tags": [{"name": "Employment Agreement", "type": "category", "uri": "/contracts/tagged/employment-agreement"}, {"name": "Aspenbio Inc", "type": "company", "uri": "/company/1167419/aspenbio-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}, {"intro": "", "id": "grY5fwuWmTc", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997313000380/ex1x1.htm", "category_name": "Purchase Agreement", "company_name": "Venaxis, Inc.", "created": "May 30th, 2013", "published": true, "pretty": null, "uri": "/contracts/grY5fwuWmTc", "title": "10,000,000 Shares of Common Stock1 and Warrants to Purchase 3,500,000 Shares of Common Stock Venaxis, Inc. PURCHASE AGREEMENT", "group_id": "tjNcgcRw6O", "group_samples": [{"label": "Purchase Agreement (Quantum Fuel Systems Technologies Worldwide, Inc.)", "uri": "/contracts/tjNcgcRw6O", "published": true}, {"label": "Purchase Agreement (Venaxis, Inc.)", "uri": "/contracts/grY5fwuWmTc", "published": true}], "group_size": 2, "tags": [{"name": "Purchase Agreement", "type": "category", "uri": "/contracts/tagged/purchase-agreement"}, {"name": "Venaxis, Inc.", "type": "company", "uri": "/company/1167419/venaxis-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "CONSULTING AGREEMENT (the \"Agreement\") dated as of February 21, 2018 (the \"Effective Date\") by and between Ingenium International LLC (the \"Consultant\") and Riot Blockchain, Inc. a Nevada corporation (the \"Company\").", "id": "1NfYsRjrhNC", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997318000125/ex10x1.htm", "category_name": "Consulting Agreement", "company_name": "Riot Blockchain, Inc.", "created": "February 23rd, 2018", "published": true, "pretty": null, "uri": "/contracts/1NfYsRjrhNC", "title": "CONSULTING AGREEMENT", "group_id": "1NfYsRjrhNC", "group_samples": [{"label": "Consulting Agreement (Riot Blockchain, Inc.)", "uri": "/contracts/1NfYsRjrhNC", "published": true}], "group_size": 1, "tags": [{"name": "Consulting Agreement", "type": "category", "uri": "/contracts/tagged/consulting-agreement"}, {"name": "Riot Blockchain, Inc.", "type": "company", "uri": "/company/1167419/riot-blockchain-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This First Amendment (this \u201cAmendment\u201d), dated as of August [__], 2017, to the Securities Purchase Agreement, dated as of March 15, 2017 (the \u201cAgreement\u201d), is entered into by and among Bioptix, Inc. (the \u201cCompany\u201d), the Majority in Interest and the Lead Investor. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement.", "id": "1Uqh6ADrQJL", "source_url": "https://www.sec.gov/Archives/edgar/data/1167419/000107997317000535/ex99x1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Bioptix, Inc.", "created": "September 1st, 2017", "published": true, "pretty": null, "uri": "/contracts/1Uqh6ADrQJL", "title": "FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT", "group_id": "1Uqh6ADrQJL", "group_samples": [{"label": "Securities Purchase Agreement (Bioptix, Inc.)", "uri": "/contracts/1Uqh6ADrQJL", "published": true}], "group_size": 1, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Bioptix, Inc.", "type": "company", "uri": "/company/1167419/bioptix-inc"}, {"name": "In vitro & in vivo diagnostic substances", "type": "industry", "uri": "/contracts/tagged/in-vitro-in-vivo-diagnostic-substances"}]}], "next_curs": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLMVVxaDZBRHJRSkwYACAB", "cursor": "CjAKEAoKZ3JvdXBfc2l6ZRICCBIKGAoIZ3JvdXBfaWQSDBoKMnFuR1RYZXFBVRgAIAE="}}